| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
79,620,000 |
| Market
Cap: |
12.77(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.1604 - $0.1604 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Soleno Therapeutics is a clinical-stage biopharmaceutical company focused on the development and commercialization of therapeutics for the treatment of rare diseases. Co.'s primary candidate is Diazoxide Choline Extended Release tablets (DCCR), a once-daily oral tablet for the treatment of Prader-Willi Syndrome. DCCR tablets consist of the active ingredient diazoxide choline, a choline salt of diazoxide, which is a benzothiadiazine.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
178,298 |
343,298 |
| Total Buy Value |
$0 |
$0 |
$1,041,856 |
$1,897,756 |
| Total People Bought |
0 |
0 |
1 |
1 |
| Total Buy Transactions |
0 |
0 |
6 |
12 |
| Total Shares Sold |
1,129,833 |
1,383,088 |
1,419,857 |
2,030,451 |
| Total Sell Value |
$52,883,521 |
$61,477,256 |
$62,474,611 |
$63,437,018 |
| Total People Sold |
5 |
5 |
5 |
6 |
| Total Sell Transactions |
6 |
23 |
27 |
76 |
| End Date |
2024-02-29 |
2023-11-28 |
2023-05-30 |
2022-05-30 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Oracle Partners Lp |
10% Owner |
– – • |
2018-05-15 |
4 |
B |
$1.93 |
$2,841 |
I/I |
1,474 |
551,423 |
1.42 |
- |
|
| Technology Partners Affiliates Vii Lp |
10% Owner |
– – • |
2018-05-14 |
4 |
A |
$3.40 |
$906,413 |
I/I |
266,592 |
37,421 |
|
- |
|
| Vivo Ventures Fund V, L.p. |
10% Owner |
– – • |
2018-05-14 |
4 |
A |
$3.40 |
$924,093 |
I/I |
271,792 |
49,456 |
|
- |
|
| Oracle Partners Lp |
10% Owner |
– – • |
2018-05-14 |
4 |
B |
$1.79 |
$86,939 |
I/I |
48,526 |
551,167 |
1.5 |
- |
|
| Technology Partners Affiliates Vii Lp |
10% Owner |
– – • |
2018-03-07 |
4 |
A |
$3.40 |
$181,281 |
I/I |
53,318 |
30,531 |
|
- |
|
| Vivo Ventures Fund V, L.p. |
10% Owner |
– – • |
2018-03-07 |
4 |
A |
$3.40 |
$184,814 |
I/I |
54,357 |
46,293 |
|
- |
|
| Engleman Edgar |
Director |
– • • |
2018-02-05 |
4 |
A |
$1.73 |
$8,749 |
I/I |
5,068 |
4,027,292 |
|
- |
|
| Shah Mahendra |
Director |
– • – |
2018-02-05 |
4 |
A |
$1.73 |
$5,983 |
D/D |
3,466 |
27,153 |
|
- |
|
| Mario Ernest |
Director |
– • – |
2018-02-05 |
4 |
A |
$1.73 |
$15,000 |
D/D |
8,689 |
704,352 |
|
- |
|
| Kirnon Stephen |
Director |
– • – |
2018-02-05 |
4 |
A |
$1.73 |
$9,319 |
D/D |
5,398 |
14,996 |
|
- |
|
| Glasheen James Walter |
Director |
– • • |
2018-02-05 |
4 |
A |
$1.73 |
$6,840 |
D/D |
3,962 |
1,419,489 |
|
- |
|
| Engelsen Steinar J |
Director |
– • – |
2018-02-05 |
4 |
A |
$1.73 |
$13,999 |
D/D |
8,109 |
41,831 |
|
- |
|
| Collinson Stuart J |
Director |
– • • |
2018-02-05 |
4 |
A |
$1.73 |
$6,582 |
D/D |
3,813 |
1,459,361 |
|
- |
|
| Dalal Rajen |
Director |
– • – |
2018-02-05 |
4 |
A |
$1.73 |
$6,582 |
D/D |
3,813 |
12,056 |
|
- |
|
| Harris William G |
Director |
– • – |
2018-02-05 |
4 |
A |
$1.73 |
$9,405 |
D/D |
5,448 |
19,184 |
|
- |
|
| Vivo Ventures Fund V, L.p. |
10% Owner |
– – • |
2017-12-15 |
4 |
B |
$1.84 |
$1,999,997 |
I/I |
1,085,480 |
45,667 |
1.5 |
- |
|
| Engleman Edgar |
Director |
– • • |
2017-12-15 |
4 |
B |
$1.84 |
$1,999,997 |
I/I |
1,085,480 |
4,033,540 |
2.25 |
- |
|
| Mario Ernest |
Director |
– • – |
2017-10-02 |
4 |
A |
$0.52 |
$15,000 |
D/D |
28,846 |
1,873,174 |
|
- |
|
| Harris William G |
Director |
– • – |
2017-10-02 |
4 |
A |
$0.52 |
$9,405 |
D/D |
18,087 |
68,679 |
|
- |
|
| Engelsen Steinar J |
Director |
– • – |
2017-10-02 |
4 |
A |
$0.52 |
$14,000 |
D/D |
26,923 |
168,612 |
|
- |
|
| Engleman Edgar |
Director |
– • • |
2017-10-02 |
4 |
A |
$0.52 |
$8,750 |
I/I |
16,827 |
14,695,186 |
|
- |
|
| Glasheen James Walter |
Director |
– • • |
2017-10-02 |
4 |
A |
$0.52 |
$6,840 |
D/D |
13,154 |
26,945 |
|
- |
|
| Shah Mahendra |
Director |
– • – |
2017-10-02 |
4 |
A |
$0.52 |
$5,985 |
D/D |
11,510 |
117,808 |
|
- |
|
| Vivo Ventures V, Llc |
10% Owner |
– – • |
2017-10-02 |
4 |
A |
$0.52 |
$8,750 |
D/D |
16,827 |
45,059 |
|
- |
|
| Dalal Rajen |
Director |
– • – |
2017-10-02 |
4 |
A |
$0.52 |
$6,584 |
D/D |
12,661 |
41,219 |
|
- |
|
389 Records found
|
|
Page 12 of 16 |
|
|
